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Abstract
The population-attributable fraction (PAF) quantifies the public health impact
of a harmful exposure. Despite being a measure of significant importance an
estimand accommodating complicated time-to-event data is not clearly defined.
We discuss current estimands of the PAF used to quantify the public health
impact of an internal time-dependent exposure for data subject to competing
outcomes. To overcome some limitations, we proposed a novel estimand which
is based on dynamic prediction by landmarking. In a profound simulation study,
we discuss interpretation and performance of the various estimands and their
estimators. The methods are applied to a large french database to estimate the
health impact of ventilator-associated pneumonia for patients in intensive care.
Keywords: Population-attributable risk, time-dependent exposure,
competing risks, hospital-acquired infection, mortality
1 Introduction
An important intention of public health decisions is the containment of fatal
exposures such as infectious diseases. A recent example is the fear of an increasing
spread of antimicrobial resistance [1]. The need for action is based on the number
of lives that could be spared if nosocomial infections (NIs) could be prevented
or entirely cured. Thus, quantifying the threat of an exposure for a population
is of main interest when taking decisions about prevention programs and the
development of new drugs.
To quantify the public health impact of a harmful exposure Levin [2] defined
the population-attributable fraction (PAF). It expresses the fraction of all cases
that are attributable to the exposure and is often interpreted as percentage of
preventable cases. The PAF is commonly estimated as a static measure over a
specific time period. A generalization has been proposed for time-to-event data
[3, 4, 5, 6, 7, 8, 9, 10]. However, these approaches are not appropriate for data
settings with an internal time-dependent exposure. We emphasize that harmful
exposures are often naturally time-dependent since – unlike in randomized clinical
trials – the time of onset cannot be chosen by the researcher. Moreover, the out-
come is often unobservable due to competing risks. This is the case if attributable
risk is quantified by cause-specific mortality or non-mortal endpoints. For exam-
ple, in hospital epidemiology, the burden of a health-care associated infection
(i.e. an NI) is often quantified in terms of death in the hospital or intensive care
unit (ICU). Then, even though observational cohort studies in ICUs have often
complete follow-up, one has to account for discharge alive as a competing risk
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to death in the ICU [11]. Additionally, infections occur over the course of time.
Ignoring the fact that NI is a time-dependent exposure leads to the so-called
time-dependent bias [12]. Another challenging aspect in this data situation is the
adjustment for time-varying confounding which is essential to draw conclusions
from observational studies. Thus, major difficulties in defining and estimating
the PAF arise when the exposure is time-dependent.
Literature on the PAF for time-dependent exposures and competing risks
is sparse [10] and inconsistent. Different proposed estimands [13, 14] lead to
different conclusions [15]. In [15], we study the differences of the approaches
by Schumacher et al. [13] and Bekaert et al. [14]. In [16], we propose a novel
estimand of the PAF which is based on dynamic prediction by landmarking [17].
The novel approach overcomes some limitations of interpretation and estimation
of the current approaches by Schumacher et al. [13] and Bekaert et al. [14]. It
provides clinically relevant implications and the estimator is easily adjustable for
time-dependent confounders.
The purpose of this article is to introduce the various ways of defining the
PAF for complex time-to-event data and to draw attention to the differences with
regard to interpretation. Our investigations include also a study of basic aspects
of the corresponding estimators of the PAF. In Section 2, we introduce the estab-
lished approaches used to define and estimate the PAF in hospital epidemiology.
Moreover, the novel approach which is discussed in detail in [16] is outlined. A
discussion and comparison of the various estimands and their estimators based
on a simulation study are presented in Section 3. In Section 4, we analyse a large
sample of ventilated patients in intensive care to estimate attributable mortal-
ity and the percentage of preventable ICU death cases if ventilator-associated
pneumonia (VAP) was avoided. For simplicity, all the methods are explained
and discussed based on the example of attributable ICU death cases due to NIs.
However, they are applicable to any other survival data setting with binary time-
dependent exposure and competing risks. Even though our focus is on data
settings with complete follow-up, all estimands can be estimated with censored
time-to-event data.
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2 The population-attributable fraction for time-
dependent exposures: Estimands and estima-
tors
2.1 Initial definition of the PAF
The PAF is defined by
PAF =
P (D = 1)− P (D = 1|E = 0)
P (D = 1)
, (1)
whereD is the random variable of a dichotomous outcome and E of a dichotomous
exposure [18]. The sampling schemes that correspond to such an estimand are
usually cross-sectional studies and cohort studies of fixed length. Note that D
and E are both observable random variables. An equivalent definition in terms
of the relative risk (RR) [19] is
PAF = P (E = 1|D = 1)× RR− 1
RR
. (2)
This representation shows that the PAF takes both the prevalence of the expo-
sure and the strength of association of exposure and outcome into account. In
cross-sectional studies and cohort studies of fixed length with a time-independent
exposure the PAF can be interpreted causally if it has been sufficiently adjusted
for confounding. Then, it can be interpreted as proportion of preventable death
cases if exposure was completely extinct [20].
2.1.1 Defining PAFcrude
If follow-up is complete, information on exposure and outcome is often summa-
rized in a fourfold table. A patient that is discharged alive has the realization
D = 0. A patient that died in the ICU has the realization D = 1. Patients
acquiring an infection during their ICU stay have E = 1, otherwise E = 0.
Then, the percentage of attributable ICU death cases is often accessed with (1)
or (2). The resulting estimand relates the proportion of patients that were ever
infected to the proportion of patients that remained uninfected until the end of
their ICU stay. We denote this estimand with PAFcrude. In clinical literature this
is still the most commonly used approach. However, PAFcrude ignores the time-
dependencies of exposure and outcome and is therefore only a crude measure of
attributable risk.
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2.1.2 Estimating PAFcrude
Estimation of PAFcrude can be performed with the R-package ’AF’ [21] which is
based on generalized-linear models (GLMs). The R-package allows for adjustment
for confounding based on the maximum likelihood estimator from a logistic model
as proposed by Greenland and Drescher [22]. Note that in case of censoring,
PAFcrude can be estimated by PAFo(τ), where τ denotes the end of follow-up.
This approach is explained in the following Section 2.2 and discussed in more
detail in Section 3.
2.2 Defining PAFo(t)
In order to account for the timing of exposure and outcome, Schumacher et al.
[13] extended the definition of PAFcrude to
PAFo(t) =
P (D(t) = 1)− P (D(t) = 1|E(t) = 0)
P (D(t) = 1)
, (3)
where D(t) is the random variable that indicates if the patient died in the ICU
by time t (D(t) = 1 if the patient died) and E(t) if the patient acquired an
NI by t (E(t) = 1 if the patient acquired an NI within (0, t]). Both E(t) and
D(t) are observable random variables. By definition of NIs patients are naturally
unexposed at study entry. Thus, E(0) = 0 for all patients. PAFo(t) relates the
proportions of patients that died infection-free within (0, t] to the proportion of
all patients that died. Therefore, it is interpretable as the observable proportion
of attributable death cases until time t among all initially admitted patients [15].
2.2.1 Estimating PAFo(t)
For identification and estimation Schumacher et al. [13] proposed to use the
multi-state model shown in Figure 1. This model is often called ’extended illness-
death model’ [23]. The exposure is modelled as an intermediate state (State 1),
the outcome death in the ICU as State 3 if the patient died unexposed and as
State 5 if the patient acquired an NI before death. Analogously, discharge alive
is modelled as State 2 and State 4.
Based on the extended illness-death model and with the Bayes’ Theorem the
conditional probability of ICU death is identifiable by
P (D(t) = 1|E(t) = 0) = P03(0, t)
P00(0, t) + P02(0, t) + P03(0, t)
, (4)
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0: Admission
to the ICU
1: Nosocomial
Infection (NI)
2: Discharge 
(without NI)
3: Death 
(without NI)
4: Discharge 
(with NI)
5: Death 
(with NI)
α03( t)
α01(t)
α14(t ) α15(t)α02(t )
Figure 1: Extended Illness-Death Model with hazard rates α01(t), α02(t), α03(t),
α14(t) and α15(t).
where P0j(0, t) (j = 0, 2, 3) denote the transition probabilities of the extended
illness-death model [13]. Moreover, the sum of the risk to die without and with
the exposure results in an estimand of overall mortality:
P (D(t) = 1) = P03(0, t) + P05(0, t). (5)
Estimation of the transition probabilities can be, for example, performed with
the Aalen-Johansen estimator. To adjust for confounding, [24] proposed a semi-
parametric modelling approach. Alternatively, the Aalen-Johansen estimators
can be estimated within strata based on baseline covariates. Confidence-intervals
can be obtained with a bootstrap approach.
2.3 Defining PAFc(t)
An alternative definition of the PAF for data settings with time-dependent ex-
posure and competing risks was motivated by Bekaert et al. [14] and formalized
by von Cube et al. [15]. We denoted this estimand with PAFc(t). The initial
definition was based on counterfactual outcomes. In this article, we use a slightly
different approach to define PAFc(t). This approach is based on the definition of
the PAF (for cross-sectional studies and cohort studies of fixed length) by Eide
et al.[25].
Let D(t) be, as defined above, the observable random variable of death by
time t and P the corresponding distribution in the target population. Thus,
P (D(t) = 1) is - as in (3) - the (observable) overall death risk. To denote the
hypothetical death risk of this population if the exposure could be eliminated -
all other things left equal - we define the distribution P0 of D(t). Then, PAFc(t)
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is given by
PAFc(t) =
P (D(t) = 1)− P0(D(t) = 1)
P (D(t) = 1)
, (6)
where P0(D(t) = 1) is the hypothetical death risk at t had all patients remained
unexposed. PAFc(t) is interpreted as the percentage of preventable ICU death
cases over the course of time had all patients remained infection-free.
2.3.1 Estimating PAFc(t)
To identify PAFc(t), we must identify the two distributions, P and P0, of the
random variable D(t). P corresponds to the distribution of D(t) in the observable
population and can be identified by (5). P0 is the hypothetical distribution after
a manipulation of the transition intensities of the extended illness-death model
(Figure 1). We only consider an indirect manipulation of the death risk by setting
the infection hazard to zero. The resulting distribution of D(t) corresponds to
P0. Now P0(D(t) = 1) can be identified with the cumulative-incidence function
(CIF) of death without NI. For estimation, patients that acquire an infection
are treated as censored observations instead of accounting for NI as a competing
risk. An estimator for the CIF is, for example, the Aalen-Johansen estimator.
We denote this estimator with Pˆ030(0, t). For details we refer to [15] and the
Appendix.
Bekaert et al. propose two estimators of P0(D(t) = 1). The first is called
naive, as it is not adjusted for counfounding factors. We emphasize that this
naive estimator is an estimator for the conditional probability function (4) [15].
Thus, the resulting estimand of the PAF is PAFo(t). Furthermore, Bekaert et al.
propose to adjust PAFc(t) by adjusting P0(D(t) = 1) using inverse probability
weights (IPWs). The weights denote the probability of being uninfected at time
t conditional on observable covariates (time-dependent and time-independent).
The weights can be derived using pooled logistic regression. The causal interpre-
tation is justified if the IPWs are correctly specified at each time t and under the
usual assumptions of marginal structural models [26]. We emphasize that in the
absence of confounding, this estimator is equivalent to Pˆ030(0, t) [15]. The result-
ing estimand is PAFc(t). In this article, we are mainly interested in the estimands
of the PAF and consider simulation studies without confounding. However, in
practice adjustment for time-varying confounding is essential to draw causal con-
clusions. Then, the IPW-approach by Bekaert et al. [14] provides a way to adjust
P̂AFc(t) for time-varying confounding. To obtain confidence intervals a bootstrap
approach can be used.
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2.4 Defining PAFLM
A different way to define the PAF while accounting for the time-dependencies of
exposure and outcome is via dynamic prediction by landmarking [16]. Generally
speaking, this is done by choosing a set of relevant time points on the study time
scale (landmarks) and an adequate time window (e.g. the mean length of stay in
the ICU). At each landmark the exposure state is updated and kept fixed over
the time-window. Then, at each landmark a PAF within the time window can be
defined with the time-independent definitions (1) or (2). The PAF at a specific
landmark provides information for the patient population that remained in the
ICU until that day. The exposed patients are those patients, that are still in
the ICU at the landmark and acquired an infection some time before or at the
landmark. The unexposed patients are those that are NI-free at the landmark.
As the PAF is defined over a specific time window it quantifies the proportion of
attributable death cases which occur within the time window. These attributable
cases could be prevented if NIs could be eliminated for patients being infected
at the landmark if the Markov assumption holds [16]. By considering a whole
set of landmarks, we account for the time-dependency of infections. A graphical
presentation of PAFLM is given in Figure 2.
Let Al indicate whether the patient is still at risk at landmark l, El if the
patient was exposed at l and Dl,h if the patient died within (l, l + h]. Then, the
PAF at a landmark l within a time window (l, l + h] is defined by
PAF(l, h) =
P (Dl,h = 1|Al = 1)− P (Dl,h = 1|El = 0, Al = 1)
P (Dl,h = 1|Al = 1) (7)
or equivalently as
PAF(l, h) = P (El = 1|Al = 1, Dl,h = 1)× RRl,h − 1
RRl,h
= PEl ×
RRl,h − 1
RRl,h
(8)
where PEl is the prevalence of infection at time l among death cases occurring
within the time window (l, l + h] and RRl,h is the RR of death within (l, l + h]
depending on the infection state at time point l. RRl,h is formally defined by
RRl,h =
P (Dl,h = 1|Al = 1, El = 1)
P (Dl,h = 1|Al = 1, El = 0) , (9)
PAFLM is the set of estimands PAF(l, h)s over all landmarks. It accounts for the
time-dynamics of the study population by considering a range of time points l.
Remark that at each landmark we consider a different target population.
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Time since study entry
0 l1 l2
Sliding time-
window of h days
l1+h l2+h
Figure 2: Dynamic prediction by landmarking: l1, l2 are landmarks, h is the time
window of fixed length; PAF (l1, h) is a summary measure over the time-interval
(l1, l1 + h].
2.4.1 Estimating PAFLM
A major strength of PAFLM is the simplicity of its’ estimation. Generally, time-
dependent confounding is a major challenge in the estimation of the PAF for
time-dependent exposures. However, at a landmark l estimation of PAFLM is
equivalent to estimation of the PAF in a data setting with baseline exposure and
fixed length of follow-up. More explicitly, estimation of PAF(l, h) is based on
estimation methods for PAFcrude since at each landmark and for every chosen
time window, information of exposure and outcome can be summarized in a four-
fold table. Time-varying confounding is accounted for by updating the covariate
values at every landmark.
For estimation, we must first identify a set of relevant landmarks. The choice
of landmarks depends on the number of exposed and unexposed patients in the
study sample. The number of patients in each group must be sufficiently large
such that the regression model converges. Inference at a landmark l is performed
on a so-called landmark dataset [17]. For a specific landmark l, it includes infor-
mation on the patients that are still at risk at l. All other patients are excluded.
The necessary information comprise exposure state at l, outcome state at l + h
and covariate values at l. If the patient is still alive at l + h or experienced a
competing event, then Dl,h = 0 otherwise Dl,h = 1. In case of censoring pseudo-
values for Dl,h as proposed by Nicolaie et al. [27] can be used [16]. With the
landmark dataset at landmark l, PAF(l, h) can be estimated with any method
available for the time-independent PAF (e.g. [28, 22, 29]). Confidence intervals
can be obtained in the same way.
Finally, van Houweling and Putter [17] proposed to smooth the separate esti-
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mates P̂AF(l, h) to increase the efficiency of the estimators. In principle, two dif-
ferent approaches can be used to obtain a smooth curve of the separate PAF(l, h)s
over all landmarks. Firstly, smoothing methods like splines in a linear model
or local smoothers such as ”loess” can be applied on the separately estimated
P̂AF(l, h). Secondly, a so-called supermodel can be used to obtain a smooth
curve over all landmarks directly without first fitting the separate models [17].
The supermodel is basically pooled logistic regression on the landmark datasets
stacked together to one large dataset. A regression model is fitted by accounting
for possible time-varying effects at the landmarks via interaction terms. For more
details, we refer to [16].
3 Comparison of the estimands and estimators
3.1 General aspects on the estimands
The estimands PAFo(t) and PAFc(t) are directly comparable, since they are both
cumulative measures of attributable risk over the course of time. The target
population of these two estimands are all patients admitted to the ICU or more
generally all patients initially entering the study. The PAFcrude can be viewed
as a summary measure of PAFo(t) as - in the absence of censoring - we have
PAFo(τ) = PAFcrude.
PAFo(t) and PAFc(t) differ in the choice of unexposed patients. In the defi-
nition of PAFo(t) the unexposed patients are those patients that did not acquire
an infection until t. Thus, they are an observable time-varying subpopulation of
the target population. In contrast, the unexposed patients considered in PAFc(t)
are a hypothetical patient population that differs from the factual one in being
infection-free. As a consequence, in the definition of PAFc(t) the same population
is compared under two distinct conditions.
The PAFLM differs from PAFo(t) and PAFc(t) in many aspects. Firstly, it is
not a cumulative measure over the course of time. Instead, similarly to PAFcrude,
it summarizes the information within a specific time window. Secondly, PAFLM
conditions on patients being still at risk at certain time points (the landmarks).
This means that - in contrast to PAFcrude, PAFo(t) and PAFc(t) - the target
population varies with time. The PAFLM is a summary measure of population-
attributable risk of patients still in the ICU after a certain amount of days.
In Table 2, we present the main characteristics of the four estimands and corre-
sponding estimators of the PAF. The simulation study demonstrates not only the
behaviour of the estimators but also the different interpretation of the estimands
under ideal conditions (i.e. no confounding).
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3.2 Performance in a simulation study
All the proposed estimands of the PAF can be identified with the transition
probabilities of the extended illness-death model (Figure 1), which are determined
by the five cause-specific hazard rates. Therefore, data generation was based on
the extended illness-death model. The data was generated and evaluated with
the statistical software R and the R code for the data simulation is an extension
of the simulation code provided by Heggland et al. [30]. We assumed constant
hazards and more generally time-varying Weibull hazards to obtain different data
situations. The effect of the time-dependent exposure on the outcome of interest
(death in ICU) was modelled either directly via an increased death hazard after
an infection or indirectly via a decreased discharge hazard after an infection. The
parameters of the various scenarios are presented in Table 1.
Each scenario was simulated 100 times with a sample size of 10,000 or 2,000
observations. In each run, we obtained estimates of PAFcrude, PAFo(t), PAFc(t)
and PAFLM . The estimates of PAFcrude and PAFLM were obtained with general-
ized linear models using the R-function glm [31]. Those for PAFo(t) and PAFc(t)
were obtained with the R-function etm [32]. To present the results we evaluated
at each time point a summary (1st to 3rd quartile and the mean) of the 100
estimates.
3.3 Data settings with time-constant hazards
We considered six different scenarios with constant hazards (see Table 1). In the
following, we discuss Scenario 4 in more detail. In this scenario, we simulated
a data setting with hazard rates α03(t) = 0.01, α15(t) = 0.02 and α02(t) =
α14(t) = 0.02. The infection hazard was quite high with α01(t) = 0.05. Due to
the inceased death hazard with infection, we expect an increased risk of death
for exposed patients. The results of Scenario 4 (10,000 observations) are shown
in Figure 3. The results of Scenarios 1-3 and 5,6 lead to similar conclusions and
are shown in the electronic supplementary material (ESM).
First, we consider P̂AFLM which is presented in the upper graphs of Figure
3 (separate models left, smoothed supermodel right). We find that due to an in-
creasing prevalence of infection within the time window, P̂AFLM becomes higher
at later landmarks. Thus, patients at risk at late time points would benefit most
of a preventive intervention provided at the specific landmark. Regarding the
estimators, the supermodel increases the efficiency of the separate models. How-
ever, variation of both estimators (separate models and supermodel) is quite large
since the landmark datasets are much smaller in size than the initial population.
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Data scenarios in the simulation study
Scenarios with constant hazards
(αij(t) = αij; i = 0, 1, j = 1, 2, 3, 4, 5; cause specific hazard rates of the extended
illness-death model (Figure 1)
Parameters of the cause-specific hazard rates
Scenario (fig. w/results) NI Discharge Death Discharge Death
w/out NI w/out NI w/NI w/NI
No effect on mortality:
1 (fig. A1 (ESM)) α01 = 0.005 α02 = 0.02 α03 = 0.01 α14 = 0.02 α15 = 0.01
2 (fig. A2 (ESM)) α01 = 0.05 α02 = 0.02 α03 = 0.01 α14 = 0.02 α15 = 0.01
Direct effect on mortality:
3 (fig. A3 (ESM)) α01 = 0.005 α02 = 0.02 α03 = 0.01 α14 = 0.02 α15 = 0.02
4 (fig. 3) α01 = 0.05 α02 = 0.02 α03 = 0.01 α14 = 0.02 α15 = 0.02
Indirect effect on mortality:
5 (fig. A4 (ESM)) α01 = 0.005 α02 = 0.03 α03 = 0.01 α14 = 0.02 α15 = 0.01
6 (fig. A5 (ESM)) α01 = 0.05 α02 = 0.03 α03 = 0.01 α14 = 0.02 α15 = 0.01
Scenarios with time-varying Weibull hazards (fig. A6 and A8 (ESM))
(αij(t) = kijλij(λijt)
kij−1; i = 0, 1, j = 1, 2, 3, 4, 5); cause specific hazard rates of the extended
illness-death model (Figure 1)
Parameters of the cause-specific hazard rates
Scenario (fig. w/results) NI Discharge Death Discharge Death
w/out NI w/out NI w/NI w/NI
Indirect effect on mortality:
7 (fig. 4) k01 = 1 k02 = 1.4 k03 = 0.9 k14 = 1.4 k15 = 0.9
λ01 = 0.06 λ02 = 0.08 λ03 = 0.05 λ14 = 0.05 λ15 = 0.05
8 (fig. A7 (ESM)) k01 = 1 k02 = 0.9 k03 = 1.4 k14 = 0.9 k15 = 1.4
λ01 = 0.06 λ02 = 0.08 λ03 = 0.05 λ14 = 0.05 λ15 = 0.05
Direct effect on mortality:
9 (fig. A9 (ESM)) k01 = 1 k02 = 1.4 k03 = 0.9 k14 = 1.4 k15 = 0.9
λ01 = 0.06 λ02 = 0.05 λ03 = 0.05 λ14 = 0.05 λ15 = 0.08
10 (fig. A10 (ESM)) k01 = 1 k02 = 0.9 k03 = 1.4 k14 = 0.9 k15 = 1.4
λ01 = 0.06 λ02 = 0.05 λ03 = 0.05 λ14 = 0.05 λ15 = 0.08
Table 1: Each scenarios was simulated 100 times with 10,000 and 2000 observations in each
run. The R code was based on the simulation code provided by Heggland et al.[30]. In each
run the four estimators of the PAF were calculated. Then, summary statistics over the 100
runs were obtained.
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The PAFo(t) (lower graph on the left) is negative in the first part of the
time frame. As explained previously [13, 33] this rather undesirable property
results from death cases accumulating later among exposed patients than among
unexposed patients. The apparent ’bump’ resulting from this time delay is a
characteristic of the estimand and does not allow for a causal interpretation.
The different simulation scenarios (see also the ESM) demonstrate that the in-
fection hazard influences the depth of the bump and the speed of convergence of
the estimand. Furthermore, the limit of PAFo(t) equals PAFcrude which relates
the observable proportion of death cases of eventually exposed and unexposed
patients. This becomes not only apparent from the simulation study but can
be also shown mathematically [33]. In the presence of censoring, P̂AFcrude is
unobservable and P̂AFo(τ) is the best approximation of it. Finally, variation of
P̂AFo(t) is minor and decreases with increasing infection hazard.
The P̂AFc(t) (lower graph, right) is positive at all time points and overcomes
the interpretational limitations of PAFo(t) (see especially Scenarios 1 and 2 in the
ESM). In Scenario 4, P̂AFc(t) increases quickly and first exceeds P̂AFcrude before
decreasing again. Thus, after removal of the exposure risk deaths accumulate
more slowly. This means that some death cases that could have been prevented
around day 50 would still occur later in time. For constant hazards (however
not generally [15]) it can be shown mathematically that P̂AFc(t) should equal
P̂AFcrude at the end of follow-up. Nevertheless, despite complete follow-up, this
is not the case in Scenario 4 due to the large infection hazard and the accordingly
high systematic censoring of infected patients. Remark that the estimand PAFc(t)
is independent of the infection hazard. However, as patients with an infection
are treated as censored observations, the estimator P̂AFc(t) loses precision with
an increasing infection hazard. Moreover, compared to P̂AFo(t) , P̂AFc(t) seems
to be less precise.
3.4 Data settings with time-varying Weibull hazards
To investigate the estimands and estimators of the PAF for a time-dependent
exposure with time-varying hazards, we further simulated data based on Weibull
hazards. We investigated four scenarios (see Table 1). In the following, we discuss
Scenario 7 (Figure 4, 10,000 observations) in detail. The argumentation and
discussion are similar for the other scenarios (shown in the ESM; ESM Figures
A7, A9 and A10). In Scenario 7, we assumed equal, decreasing death hazards
and differential increasing discharge hazards. The discharge hazard of patients
with infection was reduced compared to the one of patients without infection.
In Scenario 7, P̂AFcrude is almost zero. This is rather surprising as we would
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Figure 3: Scenario 4: Simulation of a direct effect of the exposure on the death
risk with constant cause-specific hazard rates (α01(t) = 0.05, α02(t) = 0.02,
α03(t) = 0.01, α14(t) = 0.02 and α15(t) = 0.02). Each sample consisted of 10,000
observations. The time window of P̂AFLM was the approximate mean length of
stay (30 days).
expect an increased death risk due to a decreased discharge hazard with infec-
tion. The same applies for P̂AFo(t). It is negative in the first part of the time
frame and then converges from below zero to P̂AFcrude. In contrast, both P̂AFc(t)
and P̂AFLM imply an increased death risk for infected patients and a significant
amount of preventable death cases at later time points. Due to the fact that there
is no administrative censoring and no confounding, we are able to draw direct
14
conclusions on the estimands. This simulation setting shows that PAFcrude has
no causal interpretation [15]. The discrepancy between the results is mainly ex-
plained by the death hazards which are strongly decreasing within the first days.
At this time, only a few patients already had an infection and most patients are
at risk to die without an infection. Later, when the death hazards are already
considerably decreased, more and more patients become at risk to die with in-
fection. Therefore, the absolute number of patients that die without infection
and with infection within the complete study period is almost the same despite
an indirect effect of the infection via a decreased discharge hazard. However,
interpretation must be done carefully as this equal number is rather due to the
time delay of the occurrence of infections than the severity of infections. The
time delay is not a causal consequence (though a natural aspect) of the exposure.
In the landmark approach patients that died or were discharged before the
landmark no longer influence the estimand/estimate. The difference compared
to PAFo(t) or PAFcrude arises from considering different target populations and
different unexposed patients. The P̂AFc(t) remains zero until the difference of
the discharge hazards without and with NI becomes more pronounced. Then,
P̂AFc(t) starts to increase and finally converges. The difference to PAFo(t) and
PAFcrude arises from the different definition of unexposed patients. The estimator
P̂AFc(t) seems to give precise results as variation is small. However, due to the
systematic censoring of infected patients, it can be unreliable. All estimators
performed better when the sample size was 10,000. A sample size of 2,000 led to
higher variations especially of the landmark approach. The main characteristics
of the estimands and estimators of the PAF are summarized in Table 2.
Figure 4: Scenario 7: Simulation of an indirect effect of the exposure on the
death risk with time-varying cause-specific Weibull hazard rates (the according
hazards are shown in the upper graph of ESM Figure A6). Each sample consisted
of 10,000 observations. The time window of P̂AFLM was the approximate mean
length of stay (8 days).
Estimands of the PAF for data with internal time-dependent exposure and competing risks
Definition Time scale Target population Unexposed patients
PAFcrude =
P (D=1)−P (D=1|E=0)
P (D=1)
0
complete study time
τ
All patients Patients unexposed at
= PAFo(τ) Summary measure the end of their ICU-stay
PAFo(t) =
P (D(t)=1)−P (D(t)=1|E(t)=0)
P (D(t)=1)
0 t (study time)
All patients Patients unexposed at t
Cumulative measure
PAFc(t) =
P (D(t)=1)−P0(D(t)=1)
P (D(t)=1)
0 t (study time)
All patients All patients (hypo-
Cumulative measure thetically unexposed)
PAFLM = {PAF(l, h)|l ∈ LM}
h
0 l1 l2
h
τ
All patients still Patients unexposed
PAF(l, h) = PEl × RRl,h−1RRl,h Summary measure at risk at the LM at the LM
Table 2: D and D(t) are the variables of death at the end of the ICU stay and at time t respectively; P is the factual distribution of D(t); P0
the one after artificial removal of exposure risk; PEl is the proportion of exposed at time l among ICU death cases within (l, l + h] of patients
at risk at l; RRl,h is the relative risk of death in ICU within (l, l+ h] depending on exposure at landmark l among patients at risk at l. LM is
the set of landmarks.
Estimands of the PAF for data with internal time-dependent exposure and competing risks
Estimand Interpretation Advantages Disadvantages
(see also Section 3)
PAFcrude % of observable attributable Based on observable Cannot capture time-varying
death cases at random variables effects;
the end of follow-up No causal interpretation
PAFo(t) % of observable attributable Based on observable No causal interpretation
death cases until t random variables
PAFc(t) % of preventable death cases Most consistent
until t with initial definition
PAFLM % of preventable death cases Accounts for time dynamic Depends on choice of LMs
within time window h target population; and time window;
had the exposure been prevented Based on observable variables; Does not result in a single number
at the LM Causal interpretation possible
Estimator R-function Advantages Disadvantages
P̂AFcrude glm Easily adjusted for No adjustment for
(time-independent) covariates; time-dependent covariates
Efficient
P̂AFo(t) etm Efficient; No adjustment for
time-dependent covariates
P̂AFc(t) etm (Unadjusted; Adjustable for Adjustment for time-dependent cov.
No R-functions for time-dependent cov. computer intensive and elaborate;
adjusted analysis) using inverse probability weights Biased results if prevalence is high;
Strong assumptions needed
P̂AFLM glm Easily adjusted for time- Large sample size needed
dependent covariates
4 Data example: Preventable death cases among
ventilated patients in intensive care
In this section, we estimate the health impact of ventilator-associated pneumonia
(VAP) for patients in intensive care. To do so, the four estimands of the PAF
are derived and compared for a sample of the large French database Rea-Raisin
(Re´seau d’Alerte, d’Investigation et de Surveillance des Infections Nosocomiales).
The data was collected from 2004 to 2015. The data sample includes information
on 79,347 invasive-mechanically ventilated patients from 188 ICUs. All of these
patients were at least two days ventilated with a mean length of stay (LOS)
from first ventilation to discharge (dead or alive) of 17 days and a median of 12
days. After 21 days two third of the initial patient population has left the ICU.
The shortest follow-up time was three days and the longest 403 days. A VAP
was acquired by 8,320 patients of whom 2,746 died. Of the 71,027 patients that
remained VAP-free until the end of their ICU stay 22,203 patients died.
We estimate the PAF using the four discussed methods. For the landmark
approach we use a time window of 14 days and landmarks daily from day 3 until
day 70. Due to the definition of VAP, day three is the first time point where
a patient may die/be discharged with VAP. Moreover, only a small part of the
ventilated patients stay in the ICU for more than 70 days. The time window was
chosen to be between the mean and the median LOS. The landmarks are such that
enough events are observable in both patient groups (exposed and unexposed).
The results are presented in Figure 5.
The P̂AFcrude was approximately 0.6% which is the observable proportion of
attributable cases due to VAP at the end of follow-up (after 403 days). The
total number of attributable cases was 145. The P̂AFo(t) equals P̂AFcrude at the
end of follow-up. In contrast, P̂AF c(t) being interpretable as the proportion of
preventable death cases was clearly larger with 2.22% at the end of follow-up.
This corresponds to a total number of 555 preventable ICU death cases.
Both, PAFo(t) and PAFc(t), describe how the proportion of attributable or
respectively preventable cases accumulate over the course of time. As already
observed in the simulation study, P̂AF o(t) was negative in the first days. As
commonly observed in data on patients in intensive care, the discharge hazard
among uninfected patients is large in the beginning. Thus, the number of un-
exposed patients decreased quickly. The P̂AFc(t) was also negative in the first
days but eventually converged to 0.022. As the infection hazard is low systematic
censoring of infected patients does not affect the estimate P̂AFc(t) strongly.
The P̂AFLM (separate models) was close to zero from the first landmarks until
landmark 40. Then, it increased strongly reaching a peak of 11.8% at day 50.
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Thus, if VAP could’ve been prevented at day 50 for patients still in the ICU at
that day, then 11.8% of the death cases occurring within the next 14 days could’ve
been prevented. This corresponds to a total number of 50 preventable ICU death
cases among these patients. The PAFLM demonstrates at which time points the
health impact of VAP is the strongest. In this example, the smoothed P̂AFLM
leads to more efficient but less precise results. The data example demonstrates
that the supermodel should be complemented by the separate models. It is a
weighted average of the separate models with more weight on early landmarks
with many observations. A more detailed discussion on the supermodel and the
separate models as well as alternative smoothing methods is discussed in [16].
To account for potential differences between exposed and unexposed patients,
we adjusted for the available baseline covariates age, gender and severity of ill-
ness score at first day of ventilation. The estimator P̂AFLM was adjusted as
described in Section 4 assuming a common RR among different patient groups.
Both P̂AFo(t) and P̂AFc(t) were adjusted using the weighted average based on
a Cox proportional hazards model as described in [24]. The results differed only
slightly from the unadjusted analysis.
5 Discussion
In this article, we provide a comprehensive investigation of the PAF for time-
dependent exposures and competing outcomes. By reviewing existing literature
on the PAF and evaluating a novel estimand, we defined, identified and estimated
the PAF in four different ways. Based on a theoretical exploration and with a
simulation study, we discussed the differences in interpretation of the estimands,
the advantages, and disadvantages of each approach as well as the performance
of the corresponding estimators. The four estimands were used to quantify the
burden of VAP for ventilated patients in intensive care on a population level.
The PAF as initially proposed by Levin [2] defines the attributable risk due
to an exposure and is – after sufficient control for confounding – interpretable as
proportion of preventable cases. In contrast, if the exposure depends on time, the
effect measures PAFcrude and PAFo(t), which are defined with conditional proba-
bilities based on observable random variables, have no such causal interpretation.
Nevertheless, they indicate how many of the observed cases are explained by the
exposure.
The PAFc(t) seems to be the more natural extension of the PAF to time-
dependent exposures. It is defined with hypothetical probabilities and is – after
control for confounding – interpretable as proportion of preventable cases if ex-
posure was eliminated. However, PAFc(t) is based on unobservable variables
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Figure 5: Four estimates (P̂AFLM (separate models and supermodel), P̂AF o(t),
P̂AF c(t) and P̂AF crude) of the PAF of ICU mortality due to VAP for a sample
of the Rea-Raisin database.
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complicating estimation. Moreover, it fails to describe the observable accumu-
lation of death cases. In contrast, the PAFLM can be interpreted as both the
population attributable risk and – given sufficient adjustment for confounding
and the Markov property – the percentage of preventable cases.
In hospital-epidemiology, the commonly used estimand of the PAF due to
an internal time-dependent exposure is PAFcrude. This estimand does not cap-
ture the temporal dynamics. The PAFo(t) is the time-dependent counterpart
of PAFcrude. It is a more detailed description of how deaths accumulate over
the course of time. At the end of follow-up in the absence of censoring PAFo(t)
is equal to PAFcrude. In a simulation study, we demonstrated that the esti-
mands PAFo(t) and PAFcrude can differ substantially from the causal estimand
PAFc(t). However, under constant hazards both PAFo(t) and PAFc(t) converge
to PAFcrude. In this specific data situation, the PAFcrude can be interpreted
causally as the proportion of preventable cases. The simulation study showed
that due to the systematic censoring of exposed patients in the estimation pro-
cedure, estimators of PAFc(t) can be inaccurate if the prevalence of the exposure
is high. If the exposure prevalence is rather low, as in our data example, the bias
is negligible. Moreover, the difference between PAFc(t) and PAFo(t) is small in
such data settings.
Interpretation of PAFLM is substantially different from that of the other esti-
mands. Being based on patients still at risk at specific time points, the percentage
of preventable death cases is in reference to a time-dependent subpopulation of
the initial population. The subpopulations allow to differentiate between short
stayers and long stayers that are due to their extended length of stay at higher
risk of NI acquisition [34]. In contrast, PAFo(t), PAFc(t) and PAFcrude refer to
the initial population. While estimation of PAFLM and adjustment for (time-
varying) confounding is straightforward, a clear drawback of this approach is the
loss of precision due to the smaller sample size at the landmarks.
Finally, the choice of estimand depends on the intention of the study. To
quantify the benefit of an intervention PAFc(t) and PAFLM are adequate mea-
sures. If the observable burden of an exposure on the population level is of main
interest PAFo(t), PAFcrude and PAFLM provide helpful insights. Decision on the
estimand may be also data-driven. If the time of exposure is not available, only
PAFcrude can be estimated. If the no unmeasured confounding assumption is not
reasonable, PAFo(t) and PAFLM are the preferred estimands. We emphasize that
care must be taken in the interpretation of the various estimands.
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Appendix A: Mathematical identification of PAFc(t)
In this section we identify the estimand
PAFc(t) =
P (D(t) = 1)− P0(D(t) = 1)
P (D(t) = 1)
mathematically. To do so, we consider two distributions, P and P0, of the indi-
cator D(t). We defined D(t) in Section 2 by D(t) = 1 if the patient died in the
ICU by time t, otherwise D(t) = 0. P corresponds to the distribution of D(t) in
the real world and P0 to that in a hypothetical world where infections could be
prevented. An identification of the PAF (for cohort studies of fixed length) with
this approach was introduced by Eide et al.[25].
To identify the two distributions, we consider two counting processes. These
are based on the extended illness-death model shown in Figure 1 and the compet-
ing risks model shown in Figure 6. The counting process based on the extended
illness-death model is defined by (X(t), 0 ≤ t ≤ τ) and has the finite state space
S =
{
0, 1, 2, 3, 4, 5
}
. The transition probabilities are defined by
Pij(s, t) = P (X(t) = j|X(s) = i,Xs−),
where 0 ≤ s ≤ t ≤ τ , and i, j ∈ S. The stochastic process is fully characterized
by the cause-specific transition hazards – the instantaneous risk of moving from
one state to another. These quantities are defined as
αij(t) = lim
dt→0
Pij(t, t+ dt)
dt
,
where 0 ≤ t ≤ τ, i, j ∈ S. For more details we refer to Andersen et al.[35].
The counting process X describes the distribution P of D(t) in the real world
where patients may acquire an infection. The possibility to acquire an infection
is modelled by State 1 and the infection hazard α01(t). The observable death risk
in the real world was identified in Section 2 in (5).
The counting process based on the competing risks model is defined by (Y (t), 0 ≤
t ≤ τ) with finite state space R = {0, 2, 3}. The end of study time is denoted by
τ and is in our situation the same as (or smaller than) that of X . The transition
probabilities of counting process Y with history Ys are given by
Pij0(s, t) = P0(Y (t) = j|Y (s) = i,Ys−),
where 0 ≤ s ≤ t ≤ τ , and i, j ∈ R. Moreover, the hazard rates are defined by
αij0(t) = lim
dt→0
Pij0(t, t+ dt)
dt
,
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where 0 ≤ t ≤ τ, i, j ∈ R.
The counting process Y describes the hypothetical world, where everything
remains the same as in the real world except for the fact that infections can
be prevented. This implies that the rates of moving to State 2 and 3 in the
competing risks model are the same as in the extended illness-death model i.e.
α020(t) = α02(t) and α030(t) = α03(t). However, the transition probabilities of the
two counting processes differ. This is due to the fact that the infection hazard
α01(t) of the extended illness-death model is generally greater than zero. Only,
in the special case where α01(t) = 0 do we have Pij(s, t) = Pij0(s, t) for those i
and j where both quantities are defined (i.e. i = 0 and j = 2, 3).
Similarly to Allignol et al.[36], we define T := inf{t > 0|Y (t) ∈ {2, 3}} as the
final event time and YT = Y (T ) as the final absorbing state for the competing
risks model. Since under counting process Y , D(t) = 1T≤t,XT=3 we identify the
probability of D(t) in the hypothetical world by
P0(D(t) = 1) = P0(T ≤ t,XT = 3) = P030(0, t). (10)
0: Admission
to the ICU
2: Discharge 
(without NI)
3: Death 
(without NI)
α03( t)α02(t )
Figure 6: Competing risks model with hazard rates α020(t) = α02(t) and α030(t) =
α03(t).
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